Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Calcium gluconate infusion after pediatric cardiac surgery
IRCT20260615069812N1Phase 3Recruiting
- Sponsor
- Shahid Beheshti University of Medical Sciences
- Start
- Jun 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of calcium gluconate in Cardiovascular Malformation (CVM) (2 arms), sponsored by Shahid Beheshti University of Medical Sciences. Primary endpoints: ICU length of stay, Hospital length of stay and 6 more. Started Jun 2026; status: recruiting.
02
Drugs
calcium gluconate
03
Conditions
Cardiovascular Malformation (CVM)
Beyond the preview
Go deeper on IRCT20260615069812N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20260615069812N1.